New York, United States
Commodore Capital is a healthcare investment firm. We use a science-driven approach to invest in innovative companies that are developing medical products to meaningfully improve patients’ lives. The fund is designed to make long term investments in small-cap public and late-stage private biopharmaceutical companies.
29
Total Investments
25
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Commodore Capital
Recent Investments (29)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Post Ipo Equity | •••••• | May 2026 | |
| Private Placement Vc | •••••• | Feb 2026 | |
| Private Placement Vc | •••••• | Jan 2026 | |
| Post Ipo Equity | •••••• | Aug 2025 | |
| Private Placement Vc | •••••• | Nov 2024 | |
•••• ••••
|
Post-IPO Equity | •••••• | Mar 2024 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Mar 2024 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Mar 2024 |
|
•••• ••••
|
Post Ipo Equity | •••••• | Mar 2024 |
|
•••• ••••
|
Private Placement Vc | •••••• | Feb 2024 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
